Investors in biotech stocks were getting
a little weary leading up to the Presidential elections. However, with the results in favor of Donald Trump, biotech stocks are
trading higher.
Some of the stocks are gaining significantly in Wednesday's pre-market session. Clinton was
not happy with drug pricing by pharmaceutical firms, and many feared of the price cuts and regulations her presidency might
bring to the table.
The following stocks gained in the pre-market trading on Wednesday:
-
SPDR S&P Biotech (ETF) (NYSE: XBI)
trading up 4.8 percent to $60.60
-
iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) added 4.33 percent to $272.96.
-
Valeant Pharmaceuticals Intl Inc (NYSE: VRX), which tanked 21.69 percent on Tuesday, gained 1.13 percent to $15.15.
-
Mylan NV (NASDAQ: MYL) jumped 5.85
percent to $39.28.
-
Pfizer Inc. (NYSE: PFE) advanced 7.33
percent to $32.25.
-
Eli Lilly and Co (NYSE: LLY) gained 3.01
percent to $76.25.
-
Amgen, Inc. (NASDAQ: AMGN) was up 2.82
percent to $142.35.
-
Gilead Sciences, Inc. (NASDAQ: GILD)
added 1.94 percent to $75.50.
-
Merck & Co., Inc. (NYSE: MRK) gained 2.88
percent to $62.25.
-
Novartis AG (ADR) (NYSE: NVS) advanced
2.41 percent to $73.00.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.